● From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
● The group's activity appears highly profitable thanks to its outperforming net margins.
● Analysts covering this company mostly recommend stock overweighting or purchase.
● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
● Analyst opinion has improved significantly over the past four months.
Weaknesses
● The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
● As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
● The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
● The firm trades with high earnings multiples: 25.3 times its 2023 earnings per share.
● Based on current prices, the company has particularly high valuation levels.
● The company is not the most generous with respect to shareholders' compensation.
● For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
● Revenue estimates are regularly revised downwards for the current and coming years.
● Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.